Karyopharm Therapeutics Inc
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.72 | 4.41 | 4.30 | 4.16 | 4.65 | 3.64 | 3.54 | 4.40 | 5.08 | 1.87 | 1.42 | 1.16 | 5.07 | |
| 0.12 | 0.20 | 0.26 | 0.15 | 0.16 | 0.16 | 0.15 | 0.12 | 0.24 | 0.08 | 0.05 | 0.04 | 0.21 | |
| 4.60 | 4.21 | 4.04 | 4.00 | 4.50 | 3.48 | 3.39 | 4.28 | 4.84 | 1.79 | 1.36 | 1.12 | 4.86 | |
| 4.66 | 5.14 | 4.59 | 3.72 | 4.34 | 3.97 | 4.09 | 3.80 | 3.52 | 1.52 | 1.37 | 1.03 | 4.21 | |
| 4.04 | 4.01 | 3.84 | 3.02 | 3.32 | 3.24 | 3.23 | 3.30 | 3.07 | 1.25 | 1.08 | 0.90 | 3.52 | |
| 8.70 | 9.15 | 8.43 | 6.74 | 7.65 | 7.21 | 7.32 | 7.11 | 6.59 | 2.77 | 2.45 | 1.90 | 7.70 | |
| -4.10 | -4.94 | -4.39 | -2.73 | -3.15 | -3.73 | -3.93 | -2.83 | -1.76 | -0.98 | -1.08 | -0.78 | -2.85 | |
| 0.80 | 0.81 | 0.76 | 0.87 | 1.37 | 1.34 | 1.30 | 1.30 | 1.27 | 0.69 | 0.51 | 0.45 | 1.70 | |
| -4.52 | -5.45 | -4.84 | 2.32 | -3.84 | -3.68 | -2.77 | -4.32 | -3.82 | -5.61 | -0.91 | -2.32 | -7.77 | |
| 0.00 | 0.02 | 0.01 | 0.01 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | |
| -4.52 | -5.47 | -4.85 | 2.31 | -3.85 | -3.67 | -2.77 | -4.32 | -3.82 | -5.61 | -0.91 | -2.32 | -7.77 | |
| -3.72 | -4.63 | -4.07 | 3.20 | -2.47 | -2.34 | -1.46 | -3.01 | -2.60 | -4.92 | -0.40 | -1.86 | -6.08 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.